Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD).

MLA

Svensson, Maria K., et al. “Dapagliflozin Treatment of Patients with Chronic Kidney Disease without Diabetes across Different Albuminuria Levels (OPTIMISE-CKD).” Clinical Kidney Journal, vol. 17, no. 8, Aug. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1093/ckj/sfae100.

APA

Svensson, M. K., Tangri, N., Bodegård, J., Eryd, S. A., Thuresson, M., & Sofue, T. (2024). Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD). Clinical Kidney Journal, 17(8), 1–9. https://doi.org/10.1093/ckj/sfae100

Chicago

Svensson, Maria K, Navdeep Tangri, Johan Bodegård, Samuel Adamsson Eryd, Marcus Thuresson, and Tadashi Sofue. 2024. “Dapagliflozin Treatment of Patients with Chronic Kidney Disease without Diabetes across Different Albuminuria Levels (OPTIMISE-CKD).” Clinical Kidney Journal 17 (8): 1–9. doi:10.1093/ckj/sfae100.